Suppr超能文献

世界卫生组织 2021 年全球结核病报告——不容乐观的消息与遏制结核病蔓延的努力

The WHO Global Tuberculosis 2021 Report - not so good news and turning the tide back to End TB.

机构信息

Department of Medicine, Therapeutics, Dermatology and Psychiatry, Kenyatta University, Nairobi, Kenya and Department of Clinical Sciences, Liverpool School of Tropical Medicine, Liverpool, United Kingdom.

Institute for Clinical Medicine, Aarhus University, Denmark; European Travel Medicine Network, Méditerranée Infection Foundation, Marseille, France.

出版信息

Int J Infect Dis. 2022 Nov;124 Suppl 1:S26-S29. doi: 10.1016/j.ijid.2022.03.011. Epub 2022 Mar 20.

Abstract

OBJECTIVE

To review the data presented in the 2021 WHO global TB report and discuss the current constraints in the global response.

INTRODUCTION AND METHODS

The WHO global TB reports, consolidate TB data from countries and provide up to date assessment of the global TB epidemic. We reviewed the data presented in the 2021 report.

RESULTS

We noted that the 2021 WHO global TB report presents a rather grim picture on the trajectory of the global epidemic of TB including a stagnation in the annual decline in TB incidence, a decline in TB notifications and an increase in estimated TB deaths. All the targets set at the 2018 United Nations High Level Meeting on TB were off track.

INTERPRETATION AND CONCLUSION

The sub-optimal global performance on achieving TB control targets in 2020 is attributed to the on-going COVID-19 pandemic, however, TB programs were already off track well before the onset of the pandemic, suggesting that the pandemic amplified an already fragile global TB response. We emphasize that ending the global TB epidemic will require bold leadership, optimization of existing interventions, widespread coverage, addressing social determinants of TB and importantly mobilization of adequate funding required for TB care and prevention.

摘要

目的

回顾 2021 年世卫组织全球结核病报告中呈现的数据,并讨论当前全球应对措施所面临的限制。

引言和方法

世卫组织全球结核病报告整合了各国的结核病数据,并提供了对全球结核病流行情况的最新评估。我们对 2021 年报告中呈现的数据进行了审查。

结果

我们注意到,2021 年世卫组织全球结核病报告描绘了一幅相当严峻的全球结核病流行轨迹图,包括结核病发病率的年下降趋势停滞不前、结核病报告病例数下降以及估计结核病死亡人数增加。2018 年联合国结核病问题高级别会议设定的所有目标都偏离了轨道。

解释和结论

2020 年全球在实现结核病控制目标方面的表现欠佳归因于持续的 COVID-19 大流行,但在大流行之前,结核病规划已经偏离轨道,这表明大流行放大了本已脆弱的全球结核病应对措施。我们强调,要终结全球结核病疫情,需要有果敢的领导、优化现有的干预措施、广泛覆盖、解决结核病的社会决定因素,以及重要的是为结核病护理和预防筹集所需的充足资金。

相似文献

1
The WHO Global Tuberculosis 2021 Report - not so good news and turning the tide back to End TB.
Int J Infect Dis. 2022 Nov;124 Suppl 1:S26-S29. doi: 10.1016/j.ijid.2022.03.011. Epub 2022 Mar 20.
3
Global Tuberculosis Report 2020 - Reflections on the Global TB burden, treatment and prevention efforts.
Int J Infect Dis. 2021 Dec;113 Suppl 1(Suppl 1):S7-S12. doi: 10.1016/j.ijid.2021.02.107. Epub 2021 Mar 11.
4
Recovering from the Impact of the Covid-19 Pandemic and Accelerating to Achieving the United Nations General Assembly Tuberculosis Targets.
Int J Infect Dis. 2021 Dec;113 Suppl 1:S100-S103. doi: 10.1016/j.ijid.2021.02.078. Epub 2021 Mar 11.
5
The impact of the COVID-19 pandemic on the global tuberculosis epidemic.
Front Immunol. 2023 Aug 29;14:1234785. doi: 10.3389/fimmu.2023.1234785. eCollection 2023.
7
What is operational research and how can national tuberculosis programmes in low- and middle-income countries use it to end TB?
Indian J Tuberc. 2020 Dec;67(4S):S23-S32. doi: 10.1016/j.ijtb.2020.11.009. Epub 2020 Nov 23.
8
Epidemiology of Tuberculosis and Progress Toward Meeting Global Targets - Worldwide, 2019.
MMWR Morb Mortal Wkly Rep. 2021 Mar 26;70(12):427-430. doi: 10.15585/mmwr.mm7012a4.
9
Prospects for tuberculosis elimination in Ethiopia: feasibility, challenges, and opportunities.
Pan Afr Med J. 2022 Nov 17;43:146. doi: 10.11604/pamj.2022.43.146.35557. eCollection 2022.
10
Exploring the Impact of the COVID-19 Pandemic on Tuberculosis Care and Prevention.
J Pediatric Infect Dis Soc. 2022 Oct 31;11(Supplement_3):S67-S71. doi: 10.1093/jpids/piac102.

引用本文的文献

1
Burden of tuberculosis in Eastern Africa region from 1990-2021: A systematic analysis for the Global Burden of Disease 2021 Study.
PLoS One. 2025 Sep 2;20(9):e0331035. doi: 10.1371/journal.pone.0331035. eCollection 2025.
2
Prevalence and contributing factors of drug-resistant tuberculosis (DR-TB) in iran: a systematic review.
BMC Infect Dis. 2025 Aug 8;25(1):1004. doi: 10.1186/s12879-025-11439-8.
3
Unveiling the potential of antimicrobial peptides to combat Mycobacterium tuberculosis.
Arch Microbiol. 2025 Jul 17;207(9):199. doi: 10.1007/s00203-025-04393-1.
4
A Novel Nomogram to Differentiate Between Renal Tuberculosis and Nontuberculous Renal Infection.
Infect Drug Resist. 2025 Jul 11;18:3471-3479. doi: 10.2147/IDR.S515231. eCollection 2025.
6
Public-private partnership to end tuberculosis: challenges and opportunities.
Int J Equity Health. 2025 Jul 4;24(1):195. doi: 10.1186/s12939-025-02516-0.
7
Plasma lipidomic analysis reveals distinct lipid alterations in patients with pulmonary tuberculosis.
Eur J Med Res. 2025 Jul 3;30(1):566. doi: 10.1186/s40001-025-02835-6.
9
Approaches and results of intersectoral actions for tuberculosis control in the world: A scoping review.
PLoS One. 2025 Jun 26;20(6):e0326784. doi: 10.1371/journal.pone.0326784. eCollection 2025.
10
Households of tuberculosis (TB) patients face high TB-related costs in Somalia.
BMC Glob Public Health. 2025 Jun 11;3(1):53. doi: 10.1186/s44263-025-00175-5.

本文引用的文献

1
An Update on Tuberculosis Vaccines.
Methods Mol Biol. 2022;2410:387-409. doi: 10.1007/978-1-0716-1884-4_20.
2
Gauging the impact of the COVID-19 pandemic on tuberculosis services: a global study.
Eur Respir J. 2021 Nov 11;58(5). doi: 10.1183/13993003.01786-2021. Print 2021 Nov.
4
COVID-19 Pandemic and Equal Access to Vaccines.
Vaccines (Basel). 2021 May 21;9(6):538. doi: 10.3390/vaccines9060538.
6
Recovering from the Impact of the Covid-19 Pandemic and Accelerating to Achieving the United Nations General Assembly Tuberculosis Targets.
Int J Infect Dis. 2021 Dec;113 Suppl 1:S100-S103. doi: 10.1016/j.ijid.2021.02.078. Epub 2021 Mar 11.
7
Tuberculosis and COVID-19 interaction: A review of biological, clinical and public health effects.
Pulmonology. 2021 Mar-Apr;27(2):151-165. doi: 10.1016/j.pulmoe.2020.12.012. Epub 2021 Jan 22.
8
World Health Organization recommendations on the treatment of drug-resistant tuberculosis, 2020 update.
Eur Respir J. 2021 Jun 4;57(6). doi: 10.1183/13993003.03300-2020. Print 2021 Jun.
9
Perspective for Precision Medicine for Tuberculosis.
Front Immunol. 2020 Oct 8;11:566608. doi: 10.3389/fimmu.2020.566608. eCollection 2020.
10
Community-wide Screening for Tuberculosis in a High-Prevalence Setting.
N Engl J Med. 2019 Oct 3;381(14):1347-1357. doi: 10.1056/NEJMoa1902129.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验